⚡ Flash Summary

Liven Pharma Limited has announced the revocation of their previously announced right shares issue. Consequently, the Share Transfer Books of the company will remain closed from November 24th, 2025, to November 25th, 2025, both days inclusive. This closure is intended to determine the entitlement of right shares that are no longer being issued. Transfers received by November 23rd, 2025, will be considered for the purpose of determining the now-revoked right shares entitlement.

📌 Key Takeaways

• ❌ Liven Pharma revokes planned right shares issuance.
• 🗓️ Share Transfer Books closure still set for November 24-25, 2025.
• 🏦 Closure is technically for determining right shares entitlement (now canceled).
• ➡️ Transfers by November 23rd, 2025, will be considered in vain.
• 🇵🇰 Announcement complies with PSX Rule Book Clause 5.6.9(b).
• 📰 Notice will be published in Pakistan Observer and Daily Pakistan on November 13th, 2025.
• 👨‍💼 Kaashif Hussain Siddiqie, CEO, signed the notice.
• 🏢 Registrar is M/S F.D. Registrar Services SMC (Pvt.) Ltd.
• 📍 Registrar located at Saima Trade Tower, I.I. Chundrigar Road, Karachi.
• 🤔 No clear reason provided for revoking right shares.

🎯 Investment Thesis

SELL. The revocation of the right shares issue raises concerns about Liven Pharma’s financial strategy and capital management. The lack of a clear explanation for the reversal creates uncertainty for investors. Price Target: A reduction of 15% from the current market price is warranted to account for the increased risk and uncertainty. Time Horizon: Short-term (3-6 months) to reflect immediate market reaction.